Sleep DisorderNCT06224972
Evaluation of the Usability and Performance Assessment of the DormoTech VLAB Device as a Home Sleep Test
An observational study of Sleep Disorder, run by Dormotech Medical at 1 site in Israel.
Trial summary
The study is a comparative, self-controlled, randomized, prospective investigation designed to assess the usability and accuracy of the DormoTech Vlab and compare its performance with a full polysomnography (PSG) study conducted over one night in a sleep lab. Read more about this study
- Who is it for?
- Ages 22 years and older
- Conditions the study is for
- Sleep Disorder
- What is being tested?
- Vlab
- Type of treatment
- Medical device
- How many people
- 47 participants
- Where
- 1 siteIsrael
- Study dates
- 13 Jun 2023to 12 Aug 2023
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 22 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Subjects were recruited in the sleep clinic by the attending physician, or sub-investigator. The participants were patients who were referred by physicians for a full sleep study at the sleep laboratory.
Who may be able to join
- Age of 22 years old and above.
- Willingness and ability to comply with the protocol requirements.
- Understanding and provision of signed and dated informed consent
Who cannot join
- Unwillingness to sign informed consent.
- Age below 22 years.
- Presence of implanted electronic devices or use of exterior electronic devices during the procedure.
- Known allergies to device materials.
- Skin irritation or open wounds at the device placement site.
- Pregnancy.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Usability and Performance Assessment of DormoTech VLAB
The study is a comparative, self-controlled, randomized, prospective investigation designed to assess the usability and accuracy of the DormoTech Vlab and compare its performance with a full polysomnography (PSG) study conducted over one night in a sleep lab. For the purpose of this study, the selected PSG device used for comparison is the Nox A1 system (K192469). Participants were required to wear the DormoTech Vlab, answer questionnaires pre and post-study, and simultaneously undergo a full PSG test using the Nox system.
The statistical methodology for this study was designed to ensure a comprehensive analysis of the data, adhering to the standards set by the International Council for Harmonisation (ICH) E3 guideline
Read the detailed description
The intended use of the V-Lab device is to serve as Type 2 Sleep test, an inexpensive, more comfortable device that can replace the full sleep study in a sleep lab and at-home environment.
The device is composed of three units, two of which are wearable and the third is a central unit responsible for communication; The head unit is worn on the face like a mask, and the body unit is a belt that is worn around the torso. After a few minutes of wearing the device, the patient will become ignorant of its presence. A small rechargeable 3V Li-ion battery operates both units.
The V-Lab system supports the connectivity of peripheral devices for capturing additional signals using Bluetooth technology, e.g. pulse oximeters. The V-Lab device collects and stores physiological signals such as EEG, EOG, EMG, Total Airflow, Snore, Respiratory Effort (Thoracic and Abdominal), Body and Head Position, and HR (derived from Plethysmography) Both the head and chest units communicate with the central units via Bluetooth, and the wearable units send the measured data to the central unit. The central unit receives the data, stores it within an internal flash drive, and transmits it via Wi-Fi to online servers for further diagnosis.
Using the recorded data, a physician can diagnose sleep disorders manually or use any sleep diagnostic system that supports EDF Formats.
The study Objectives are to assess the efficiency, usability, durability, safety, and patient satisfaction of the V-Lab device and to validate the level of agreement between the V-Lab device and a PSG.
The study's main outcome measures are patient feedback as determined by a satisfaction questionnaire, agreement and level of agreement between V-Lab and the referenced device (e.g. Bland-Altman plots of the mean versus the difference will be presented, and sensitivity and specificity analysis), and safety as defined by Adverse Events related to device use.
The study population will include patients seeking medical attention at a sleep clinic, age 22 years old and above and the subject is willing and able to comply with the requirements of the protocol, fully understands all elements of, and has signed and dated, the written informed consent form before initiation of protocol-specified procedures.
The exclusion criteria for the participants are subjects not willing to sign informed consent, subjects age is under 22 years old, subjects with implanted electronic devices of any kind, including cardiac pacemakers, or similar assistive devices, electronic infusion pumps, and implanted stimulators, subjects using exterior electronic devices of any kind during the procedure, such as TENS, or similar assistive devices, subjects with known allergies to device materials, subjects with irritated skin or open wound on the body at the site of device placement, and pregnant women.
Subjects will be recruited on two investigational sites: Shamir Medical Center- Be'er Ya'akov, Israel, and Millennium Sleep Clinic, Be'er Sheva, Israel, by the attending physician.
Subjects will go through a standard PSG monitoring which will be performed with a V-Lab device monitoring simultaneously in the sleep lab during one night.
The subject will be informed that participation in the study is voluntary, that he/she may withdraw from the study at any time and that withdrawal of consent will not affect his/her subsequent medical treatment (if any) or relationship with the treating physician. Subjects will be asked to fill out a satisfaction questionnaire and to report to the investigator Adverse Events.
Before studying active participation, the investigator will perform documentation of demography, relevant medical history, and medication consumption. The investigator will perform also a physical examination, including documentation of relevant medical and surgical history that may affect the experiment, based on the investigator's opinion (including precise diagnosis of disease) and Vital Signs (Pulse, Blood Pressure, Temperature). Steps will be taken to ensure the collected data are accurate, consistent, complete, and reliable.
- Conditions
- Sleep Disorder
- Being tested
- Vlab
- Keywords
- Sleep test, Sleep disorder, Home sleep tests, Physiological data recorder, Sleep diagnostics
- Medical subject headings
- Sleep Wake Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
VlabDevice
The study is observational, there is no intervention.
| Study group | Role | What they receive |
|---|---|---|
| Observational group | The study is observational study - one group. Receives: Device: Vlab |
What is being measured
The primary outcome is the main question the study is designed to answer.
AHI Score and Classification
The AHI (apnea-hypopnea index) score was categorized and compared according to levels of severity:
AHI = number of Apneas+Hypopneas/total sleep time
Categorizing Normal <5, Mild: 5<AHI<15, Moderate: 15<AHI<30, Severe: 30<AHI
Measured: During night 1
Secondary outcomes (8)
Total Sleep Time (min)
Time from sleep onset to sleep offset (min)
Measured: During night 1
Sleep Efficiency (%)
Total sleep time (min) / Total recorded time (min)
Measured: During night 1
Sleep Stages (%)
Wake, N1, N2, N3, REM (% from total sleep time)
Measured: During night 1
Sleep Latency (min)
Time to fall asleep from the record starting (min)
Measured: During night 1
Wake After Sleep Onset (min)
The first wake after sleep onset (min)
Measured: During night 1
REM Latency (min)
The amount of time elapsed between the onset of sleep to the first REM stage (min)
Measured: During night 1
Total snore (%)
The number of snoring episodes divided by the hours of total sleep time
Measured: During night 1
Body Position
Supine position, Left, Right, Up (% from Total Sleep Time)
Measured: During night 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Jan 2024
- Study start13 Jun 2023
- Primary completion12 Aug 2023
- Study completion12 Aug 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Sleep DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 47 participants (actual)
- Target duration
- 1 Day
Sponsor and investigators
- Lead sponsor
- Dormotech Medical
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Assaf-Harofeh Medical Center
- Responsible party
- Sponsor
- Investigators
- Benjamin D Fox, MD, Principal investigator, Assaf-Harofeh Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06224972
- Sponsor's protocol ID
- VLAB_C_T_1
- Status last verified
- Jan 2024
- First submitted
- 6 Dec 2023
- Last updated
- 25 Jan 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
Publications
Fox BD, Shihab M, Nassir A, Kushinsky D, Barnea O, Tal A. Validation of a novel mask-based device for monitoring of comprehensive sleep parameters and sleep disordered breathing. Sleep Breath. 2025 Jan 20;29(1):83. doi: 10.1007/s11325-025-03250-1.
PubMed 39833613
Study at a glance
From the registry record, last updated by the sponsor on 25 Jan 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Usability and Performance Assessment of DormoTech VLAB
- ClinicalTrials.gov ID
- NCT06224972
- Acronym / sponsor ID
- VLAB_C_T_1
- Conditions
- Sleep Disorder
- Keywords
- Sleep test, Sleep disorder, Home sleep tests, Physiological data recorder, Sleep diagnostics
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 47 participants (actual)
- Lead sponsor
- Dormotech MedicalIndustry (pharma, biotech, devices)
- Collaborators
- Assaf-Harofeh Medical Center
- Study start
- 13 Jun 2023 (actual)
- Primary completion
- 12 Aug 2023 (actual)
- Study completion
- 12 Aug 2023 (actual)
- First posted
- 25 Jan 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study is a comparative, self-controlled, randomized, prospective investigation designed to assess the usability and accuracy of the DormoTech Vlab and compare its performance with a full polysomnography (PSG) study conducted over one night in a sleep lab. For the purpose of this study, the selected PSG device used for comparison is the Nox A1 system (K192469). Participants were required to wear the DormoTech Vlab, answer questionnaires pre and post-study, and simultaneously undergo a full PSG test using the Nox system.
The statistical methodology for this study was designed to ensure a comprehensive analysis of the data, adhering to the standards set by the International Council for Harmonisation (ICH) E3 guideline
Detailed description
The intended use of the V-Lab device is to serve as Type 2 Sleep test, an inexpensive, more comfortable device that can replace the full sleep study in a sleep lab and at-home environment.
The device is composed of three units, two of which are wearable and the third is a central unit responsible for communication; The head unit is worn on the face like a mask, and the body unit is a belt that is worn around the torso. After a few minutes of wearing the device, the patient will become ignorant of its presence. A small rechargeable 3V Li-ion battery operates both units.
The V-Lab system supports the connectivity of peripheral devices for capturing additional signals using Bluetooth technology, e.g. pulse oximeters. The V-Lab device collects and stores physiological signals such as EEG, EOG, EMG, Total Airflow, Snore, Respiratory Effort (Thoracic and Abdominal), Body and Head Position, and HR (derived from Plethysmography) Both the head and chest units communicate with the central units via Bluetooth, and the wearable units send the measured data to the central unit. The central unit receives the data, stores it within an internal flash drive, and transmits it via Wi-Fi to online servers for further diagnosis.
Using the recorded data, a physician can diagnose sleep disorders manually or use any sleep diagnostic system that supports EDF Formats.
The study Objectives are to assess the efficiency, usability, durability, safety, and patient satisfaction of the V-Lab device and to validate the level of agreement between the V-Lab device and a PSG.
The study's main outcome measures are patient feedback as determined by a satisfaction questionnaire, agreement and level of agreement between V-Lab and the referenced device (e.g. Bland-Altman plots of the mean versus the difference will be presented, and sensitivity and specificity analysis), and safety as defined by Adverse Events related to device use.
The study population will include patients seeking medical attention at a sleep clinic, age 22 years old and above and the subject is willing and able to comply with the requirements of the protocol, fully understands all elements of, and has signed and dated, the written informed consent form before initiation of protocol-specified procedures.
The exclusion criteria for the participants are subjects not willing to sign informed consent, subjects age is under 22 years old, subjects with implanted electronic devices of any kind, including cardiac pacemakers, or similar assistive devices, electronic infusion pumps, and implanted stimulators, subjects using exterior electronic devices of any kind during the procedure, such as TENS, or similar assistive devices, subjects with known allergies to device materials, subjects with irritated skin or open wound on the body at the site of device placement, and pregnant women.
Subjects will be recruited on two investigational sites: Shamir Medical Center- Be'er Ya'akov, Israel, and Millennium Sleep Clinic, Be'er Sheva, Israel, by the attending physician.
Subjects will go through a standard PSG monitoring which will be performed with a V-Lab device monitoring simultaneously in the sleep lab during one night.
The subject will be informed that participation in the study is voluntary, that he/she may withdraw from the study at any time and that withdrawal of consent will not affect his/her subsequent medical treatment (if any) or relationship with the treating physician. Subjects will be asked to fill out a satisfaction questionnaire and to report to the investigator Adverse Events.
Before studying active participation, the investigator will perform documentation of demography, relevant medical history, and medication consumption. The investigator will perform also a physical examination, including documentation of relevant medical and surgical history that may affect the experiment, based on the investigator's opinion (including precise diagnosis of disease) and Vital Signs (Pulse, Blood Pressure, Temperature). Steps will be taken to ensure the collected data are accurate, consistent, complete, and reliable.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 1 Day
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Observational group | – | Device: VlabThe study is observational study - one group. |
Who may qualify
- Ages
- 22 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Subjects were recruited in the sleep clinic by the attending physician, or sub-investigator. The participants were patients who were referred by physicians for a full sleep study at the sleep laboratory.
Key inclusion criteria (3 listed)
- Age of 22 years old and above.
- Willingness and ability to comply with the protocol requirements.
- Understanding and provision of signed and dated informed consent
Key exclusion criteria (6 listed)
- Unwillingness to sign informed consent.
- Age below 22 years.
- Presence of implanted electronic devices or use of exterior electronic devices during the procedure.
- Known allergies to device materials.
- Skin irritation or open wounds at the device placement site.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| VlabThe study is observational, there is no intervention. | Device | Observational group |
Primary outcome
AHI Score and Classification
Time frame: During night 1
The AHI (apnea-hypopnea index) score was categorized and compared according to levels of severity: AHI = number of Apneas+Hypopneas/total sleep time Categorizing Normal <5, Mild: 5<AHI<15, Moderate: 15<AHI<30, Severe: 30<AHI
8 secondary outcomes
Total Sleep Time (min)
Time frame: During night 1
Sleep Efficiency (%)
Time frame: During night 1
Sleep Stages (%)
Time frame: During night 1
Sleep Latency (min)
Time frame: During night 1
Wake After Sleep Onset (min)
Time frame: During night 1
REM Latency (min)
Time frame: During night 1
Total snore (%)
Time frame: During night 1
Body Position
Time frame: During night 1
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Jan 2024.
- Derived from this study: PubMed 39833613Fox BD, Shihab M, Nassir A, Kushinsky D, Barnea O, Tal A. Validation of a novel mask-based device for monitoring of comprehensive sleep parameters and sleep disordered breathing. Sleep Breath. 2025 Jan 20;29(1):83. doi: 10.1007/s11325-025-03250-1.
Related trials for Sleep Disorder
Recruiting
NightWare and Cardiovascular Health in Women With PTSD
Post Traumatic Stress Disorder, Cardiovascular Diseases
Recruiting
Addressing Nocturia in Older Women Utilizing Behavioral Sleep Intervention and Brief Mindfulness
Nocturia, Insomnia
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Recruiting
Investigation of the Effects of Sleep Deprivation on Itch and Pain Sensitivity
Histamine, Cowhage
RecruitingObservational study
Locus Coeruleus and CCHS (Congenital Central Hypoventilation Syndrome)
Ondine Syndrome (Congenital Central Hypoventilation Syndrome)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Benjamin D Fox, MD principal investigator
Assaf-Harofeh Medical Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Sleep Disorder, run by Dormotech Medical at 1 site in Israel.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
AHI Score and Classification (time frame: During night 1). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06224972, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jan 2024.